Gemcitabine is a nucleoside analogue chemotherapeutic agent used in the treatment of various types of cancer.
EML status history
First added in 2015 (TRS 994) for Other specified carcinomas of ovary
Added in 2015 (TRS 994) for Other specified malignant neoplasms of bronchus or lung
- Parenteral > General injections > IV: 200 mg in vial powder for injection; 1 g in vial powder for injection